Trial Profile
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Diclofenac Sodium Eye-Drops (LT-0303) in Patients with dry eye syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2016
Price :
$35
*
At a glance
- Drugs Diclofenac (Primary)
- Indications Dry eyes
- Focus Therapeutic Use
- Sponsors LTT Bio-Pharma
- 26 Dec 2016 Status changed from recruiting to completed.
- 17 May 2016 New trial record